Table 4.
miRNA | No. analyzed | Events* | Effect size | SE | P value | FDR‐adjusted P value |
---|---|---|---|---|---|---|
miR‐193a‐5p | 3716 | 52 | −0.309 | 0.0649 | 1.84E‐06 | 0.000292 |
miR‐192‐5p | 3602 | 51 | −0.252 | 0.0797 | 0.00156 | 0.0422 |
miR‐320e | 3703 | 53 | −0.213 | 0.0670 | 0.00152 | 0.0422 |
miR‐122‐5p | 3830 | 55 | −0.226 | 0.0679 | 0.000885 | 0.0422 |
miR‐193b‐3p | 2380 | 37 | −0.277 | 0.0892 | 0.00186 | 0.0422 |
miR‐210‐3p | 3616 | 52 | −0.227 | 0.0685 | 0.00094 | 0.0422 |
miR‐34a‐5p | 3162 | 50 | −0.246 | 0.0784 | 0.00170 | 0.0422 |
miR‐301a‐3p | 3043 | 42 | −0.255 | 0.0831 | 0.00218 | 0.0432 |
Associations after adjustment for age, sex, cohort, and CVD risk factors. CVD indicates cardiovascular disease; FDR, false discovery rate; FHS, Framingham Heart Study; and miRNAs, microRNAs.
Number of events associated with each miRNA out of total 56 new‐onset mortality events.